Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Treasury Shares (2020 - 2025)

Celularity (CELU) has disclosed Treasury Shares for 1 consecutive years, with $256000.0 as the latest value for Q4 2020.

  • For Q4 2020, Treasury Shares changed N/A year-over-year to $256000.0; the TTM value through Dec 2020 reached $256000.0, changed N/A, while the annual FY2020 figure was $256000.0, N/A changed from the prior year.
  • Treasury Shares hit $256000.0 in Q4 2020 for Celularity.
  • Across five years, Treasury Shares topped out at $8.8 million in Q3 2023 and bottomed at $227013.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $1.9 million, with a median of $581832.0 recorded in 2025.
  • Year-over-year, Treasury Shares soared 1023.42% in 2023 and then crashed 96.28% in 2024.
  • Celularity's Treasury Shares stood at $474700.0 in 2021, then plummeted by 52.18% to $227013.0 in 2022, then soared by 262.68% to $823332.0 in 2023, then decreased by 19.91% to $659439.0 in 2024, then fell by 2.36% to $643859.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $643859.0, $488161.0, and $558530.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.